AstraZeneca to acquire Icosavax in $1.1bn deal to boost vaccine development

In a definitive move, AstraZeneca has entered into an agreement to acquire Icosavax, Inc., a U.S.-based biopharmaceutical company specializing in innovative vaccines. This acquisition, valued ... Read More